Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Alaunos Therapeutics Inc (TCRT)

Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 67,575
  • Shares Outstanding, K 16,013
  • Annual Sales, $ 10 K
  • Annual Income, $ -35,140 K
  • 60-Month Beta -0.49
  • Price/Sales 1,370.71
  • Price/Cash Flow N/A
  • Price/Book 1.43
Trade TCRT with:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 155.47%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 1,373.65% on 12/18/23
  • IV Low 0.00% on 07/19/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 37
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 13,060
  • Open Int (30-Day) 11,419

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.00 +2.00%
on 07/22/24
7.72 -47.14%
on 06/24/24
-2.92 (-41.72%)
since 06/21/24
3-Month
4.00 +2.00%
on 07/22/24
14.20 -71.27%
on 05/09/24
-6.82 (-62.57%)
since 04/22/24
52-Week
4.00 +2.00%
on 07/22/24
72.75 -94.39%
on 08/01/23
-68.04 (-94.34%)
since 07/21/23

Most Recent Stories

More News
Pre-Market Brief: Stocks Rebound As China Concerns Ease

December S&P 500 futures (ESZ22) are trending up +0.31% this morning after three major US benchmark indices finished the regular session sharply lower after protests in major Chinese cities against strict...

ESZ22 : 3,871.47s (-0.66%)
AAPL : 223.96 (-0.16%)
NAOV : 0.7261 (-4.84%)
KALA : 6.86 (+1.48%)
TCRT : 4.08 (-3.32%)
SI : 1.2500 (+0.81%)
NXST : 177.54 (+1.24%)
UPS : 145.18 (unch)
Why Alaunos Therapeutics Triumphed On Tuesday

Four of the biotech's top managers reveal they've exercised stock options, and investors are following suit by snapping up shares.

TCRT : 4.08 (-3.32%)
These 2 Stocks Stood Strong Despite the Nasdaq's Friday Fall

One is even a technology stock.

COMP : 4.47 (+0.22%)
$NASX : 18,007.57 (+1.58%)
APPN : 34.94 (-1.02%)
TCRT : 4.08 (-3.32%)
PEGA : 59.98 (+0.52%)
Why Alaunos Therapeutics Stock Is Soaring Today

The biotech is rebounding after yesterday's big sell-off.

TCRT : 4.08 (-3.32%)
Why Alaunos Therapeutics Stock Sank Today

Investors appeared to take profits off the table after the biotech's positive news last week.

TCRT : 4.08 (-3.32%)
Why Alaunos Therapeutics Topped the Market on Tuesday

A specialty cancer therapy developed by the company shows some rather promising results.

TCRT : 4.08 (-3.32%)
Why Alaunos Therapeutics Stock Is Up Yet Again Today

Shorts appear to be moving to the sidelines ahead of an upcoming presentation.

COMP : 4.47 (+0.22%)
TCRT : 4.08 (-3.32%)
Why Alaunos Therapeutics Stock Is Tumbling Today

The biotech's stock is giving back some of its recent gains.

TCRT : 4.08 (-3.32%)
Why Alaunos Therapeutics' Shares Jumped 48.9% This Week

The rise was part of an upswing that began earlier this year.

TCRT : 4.08 (-3.32%)
Why Alaunos Therapeutics Stock Was On Fire Today

The cell therapy company's shares have been crushing it this year.

TCRT : 4.08 (-3.32%)

Business Summary

Alaunos Therapeutics Inc. is a clinical-stage oncology-focused cell therapy company. It focused on developing T-cell receptor therapies based on its proprietary, non-viral Sleeping Beauty gene transfer platform. Alaunos Therapeutics Inc., formerly known as Ziopharm Oncology Inc., is based in HOUSTON....

See More

Key Turning Points

3rd Resistance Point 4.57
2nd Resistance Point 4.44
1st Resistance Point 4.26
Last Price 4.08
1st Support Level 3.95
2nd Support Level 3.82
3rd Support Level 3.64

See More

52-Week High 72.75
Fibonacci 61.8% 46.49
Fibonacci 50% 38.38
Fibonacci 38.2% 30.26
Last Price 4.08
52-Week Low 4.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar